US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

THEMES US R&D CHAMPIONS ETF

37.24

0.0000

Volume:- -

Turnover:- -

Market Cap:1.12M

PE:- -

High:37.24

Open:37.24

Low:37.24

Close:37.24

52wk High:39.83

52wk Low:30.96

Shares:30.00K

Float Shares:30.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.14

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Entropy Neurodynamics Granted South African Patent for Fibromyalgia Treatment Using Psilocybin

MT Newswires Live

VisionWave files provisional patent application for GhostSight

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Nuwellis awarded U.S. patent for Dual Lumen Catheter

Hainan Province Launches "One-Stop" Service Zone for Intellectual Property Protection

UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103

NewcelX announces Brazil patent for cell selection, enrichment technology

enVVeno Medical highlights newly issued U.S. patent

UroGen Pharma Receives US Patent Allowance for Zusduri, UGN-103

MT Newswires Live

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Seyond Holdings Reports Mixed Outcomes in LiDAR Patent Fight With Hesai

Immutep Granted New US Patent for Cancer Treatment Methods

MT Newswires Live

VisionWave Files Provisional Patent Application for SkyWeave Communication System

MT Newswires Live

VisionWave files provisional patent application covering SkyWeave

Immutep granted new patent for eftilagimod alfa combination

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Immutep Wins Fourth U.S. Patent for Key Cancer Immunotherapy Combination

Recce Wins Key Vietnamese Patent for Novel Anti-Infectives

Jiangxi Launches Pilot for Integrated "One-Stop Intellectual Property Protection" System

StemRIM Secures Canadian Patent for Regenerative Heart Drug Redasemtide

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/USRD/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"USRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","market":"US","secType":"STK","nameCN":"THEMES US R&D CHAMPIONS ETF","latestPrice":37.237,"timestamp":1789151633469,"preClose":37.237,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":30000,"shares":30000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-11 14:33:53 EDT","open":37.237,"high":37.237,"low":37.237,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":37.237,"sharesOutstanding":30000,"nav":37.28,"aum":1118400,"dividendRate":0.003776,"bidAskSpread":0,"volumeRatio":0,"impliedVol":0.1087,"impliedVolPercentile":0.1883},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"USRD\",,,,,undefined,":{"symbol":"USRD","floatShares":30000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.1406,"high":37.237,"amplitude":0,"preClose":37.237,"low":37.237,"week52Low":30.96,"pbRate":"--","week52High":39.83,"institutionHeld":0,"latestPrice":37.237,"eps":0,"divideRate":0.003776,"volume":0,"delay":0,"ttmEps":0,"open":37.237,"prevYearClose":33.9934,"prevWeekClose":37.237,"prevMonthClose":37.237,"prevQuarterClose":37.1571,"fiveDayClose":37.237,"twentyDayClose":37.237,"sixtyDayClose":37.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/USRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-29","symbol":"USRD","reason":null,"defaultRemindTime":1785331800000,"announcedDate":"2026-07-28","type":"delisting","dateTimestamp":1785297600000},{"date":"2025-12-18","symbol":"USRD","amount":0.1402666,"announcedDate":"2025-12-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-18","defaultRemindTime":1766068200000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-18","currency":"USD","dateTimestamp":1766034000000,"payDate":"2025-12-19"},{"date":"2024-12-24","symbol":"USRD","amount":0.72425,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"THEMES US R&D CHAMPIONS ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"USRD\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.72425,"currency":"USD"},{"executeDate":"2025-12-18","recordDate":"2025-12-18","paymentDate":"2025-12-19","value":0.1402666,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"USRD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"USRD\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652265468","title":"Entropy Neurodynamics Granted South African Patent for Fibromyalgia Treatment Using Psilocybin","url":"https://stock-news.laohu8.com/highlight/detail?id=2652265468","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652265468?lang=en_us&edition=fundamental","pubTime":"2026-07-20 09:25","pubTimestamp":1784510734,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  said it was granted a patent in South Africa covering methods of treating fibromyalgia using psilocybin, with a term extended to September 2043, according to a Monday Australian bourse filing.The patent provides broad intellectual property protection covering the clinical use of psilocybin for the treatment of fibromyalgia, including therapeutic methods, dosing regimens, patient selection criteria, clinical assessment protocols, biomarkers, treatment outcome measures, integration therapy, and manufacture.The patent term is subject to the payment of annual renewal fees.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","USRD","ENP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652288779","title":"VisionWave files provisional patent application for GhostSight","url":"https://stock-news.laohu8.com/highlight/detail?id=2652288779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652288779?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290525,"startTime":"0","endTime":"0","summary":"VisionWave (VWAV) announced the filing of a provisional patent application number 64/111,834 with the United States Patent and Trademark Office cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-for-ghostsight-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-for-ghostsight-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","VWAV","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652184401","title":"Arbutus Biopharma Reshapes Strategy After Moderna Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652184401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652184401?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:37","pubTimestamp":1784281058,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXTI","BBP","MEDX","BK4139","RND","USRD","ABUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651444459","title":"Nuwellis awarded U.S. patent for Dual Lumen Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2651444459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651444459?lang=en_us&edition=fundamental","pubTime":"2026-07-16 20:35","pubTimestamp":1784205327,"startTime":"0","endTime":"0","summary":"Nuwellis (NUWE) announced that the U.S. Patent and Trademark Office , or USPTO, has issued U.S. Patent No. 12,678,592, covering the company’s Dual ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nuwellis-awarded-u-s-patent-for-dual-lumen-catheter-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nuwellis-awarded-u-s-patent-for-dual-lumen-catheter-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NUWE","USRD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184549409","title":"Hainan Province Launches \"One-Stop\" Service Zone for Intellectual Property Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=1184549409","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184549409?lang=en_us&edition=fundamental","pubTime":"2026-07-16 16:00","pubTimestamp":1784188834,"startTime":"0","endTime":"0","summary":"Hainan Province has recently launched a dedicated \"One-Stop\" service zone for intellectual property protection, marking a significant step in streamlining related administrative services.This...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD","WRND","LRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651499433","title":"UroGen Pharma gets new US patent allowance into July 2044 for ZUSDURI, UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651499433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651499433?lang=en_us&edition=fundamental","pubTime":"2026-07-16 05:10","pubTimestamp":1784149812,"startTime":"0","endTime":"0","summary":"Earlier this morning, the company stated: “UroGen Pharma (URGN) announced that it has received a Notice of Allowance from the U.S. Patent and Trade...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/urogen-pharma-gets-new-us-patent-allowance-into-july-2044-for-zusduri-ugn-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/urogen-pharma-gets-new-us-patent-allowance-into-july-2044-for-zusduri-ugn-103-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["URGN","USRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651665274","title":"NewcelX  announces Brazil patent for cell selection, enrichment technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2651665274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651665274?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:15","pubTimestamp":1784121348,"startTime":"0","endTime":"0","summary":"NewcelX (NCEL)announced that the Brazilian Patent and Trademark Office has issued a patent covering its cell selection and enrichment technology. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newcelx-announces-brazil-patent-for-cell-selection-enrichment-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newcelx-announces-brazil-patent-for-cell-selection-enrichment-technology-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWZS","NCEL","USRD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465112","title":"enVVeno Medical highlights newly issued U.S. patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651465112?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:55","pubTimestamp":1784120149,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) announced that Robert Berman, Chief Executive Officer of enVVeno Medical participated in a Virtual Investor “What This Means...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-highlights-newly-issued-u-s-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-highlights-newly-issued-u-s-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","BK4082","NVNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651808463","title":"UroGen Pharma Receives US Patent Allowance for Zusduri, UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651808463","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651808463?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:30","pubTimestamp":1784118607,"startTime":"0","endTime":"0","summary":"UroGen Pharma  said Wednesday it has received a US patent allowance covering methods of treating patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer with Zusduri and investigational candidate UGN-103.The patent allowance is supported by data from two clinical trials and cover treatment without transurethral resection of a bladder tumor, the company said.The patent, once issued, is expected to expire in July 2044, UroGen said.Shares of the company were 1.1% higher in premarket activity Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","URGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651463589","title":"UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103","url":"https://stock-news.laohu8.com/highlight/detail?id=2651463589","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651463589?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:00","pubTimestamp":1784116800,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J., July  15, 2026  (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and spe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327670/0/en/UroGen-Receives-New-U-S-Patent-Allowance-Expected-to-Provide-Protection-into-July-2044-for-ZUSDURI-and-UGN-103.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651104592","title":"Seyond Holdings Reports Mixed Outcomes in LiDAR Patent Fight With Hesai","url":"https://stock-news.laohu8.com/highlight/detail?id=2651104592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651104592?lang=en_us&edition=fundamental","pubTime":"2026-07-14 22:08","pubTimestamp":1784038092,"startTime":"0","endTime":"0","summary":"TechStar Acquisition Corporation Class A ( ($HK:2665) ) has shared an announcement. Seyond Holdings has provided an update on four patent infringem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seyond-holdings-reports-mixed-outcomes-in-lidar-patent-fight-with-hesai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seyond-holdings-reports-mixed-outcomes-in-lidar-patent-fight-with-hesai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105400","title":"Immutep Granted New US Patent for Cancer Treatment Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105400","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105400?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:42","pubTimestamp":1784032963,"startTime":"0","endTime":"0","summary":"Immutep  said Tuesday it secured a new patent from the US Patent and Trademark Office covering methods for the treatment of cancer by administering eftilagimod alfa in combination with an antibody.The patent, entitled \"Combined Preparations for the Treatment of Cancer or Infection,\" expires Jan. 20, 2036, the company said.Immutep shares were 1.9% higher in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IMMP","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651210540","title":"VisionWave Files Provisional Patent Application for SkyWeave Communication System","url":"https://stock-news.laohu8.com/highlight/detail?id=2651210540","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651210540?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:42","pubTimestamp":1784032921,"startTime":"0","endTime":"0","summary":"VisionWave (VWAV) said Tuesday it has filed a US provisional patent application for SkyWeave, an AI-driven high-frequency communication system designed to provide long-range connectivity without satel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["USRD","VWAV","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103775","title":"VisionWave files provisional patent application covering SkyWeave","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103775?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:16","pubTimestamp":1784031363,"startTime":"0","endTime":"0","summary":"VisionWave (VWAV) announced the filing of a U.S. provisional patent application covering SkyWeave, a communication ecosystem designed to enable res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-covering-skyweave-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/visionwave-files-provisional-patent-application-covering-skyweave-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","BK4187","VWAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103089","title":"Immutep granted new patent for eftilagimod alfa combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651103089?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:15","pubTimestamp":1784031320,"startTime":"0","endTime":"0","summary":"Immutep (IMMP) announced the grant of a new patent entitled “Combined Preparations for the Treatment of Cancer or Infection” by the United States P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immutep-granted-new-patent-for-eftilagimod-alfa-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immutep-granted-new-patent-for-eftilagimod-alfa-combination-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD","IMMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105797","title":"Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105797","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105797?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:00","pubTimestamp":1784030400,"startTime":"0","endTime":"0","summary":"SYDNEY, AUSTRALIA, July  14, 2026  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3326779/0/en/Immutep-Secures-Fourth-United-States-Patent-for-Eftilagimod-Alfa-in-Combination-with-a-PD-1-Pathway-Inhibitor.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","USRD","BK4023","LU1169589451.USD","BK4211","UBCP","BK4139","IMMP","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651768125","title":"Immutep Wins Fourth U.S. Patent for Key Cancer Immunotherapy Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2651768125","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651768125?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:22","pubTimestamp":1783995754,"startTime":"0","endTime":"0","summary":"An update from Immutep Ltd ( ($AU:IMM) ) is now available. Immutep Limited has secured its fourth U.S. patent covering the use of its lead immunoth...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immutep-wins-fourth-u-s-patent-for-key-cancer-immunotherapy-combination?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immutep-wins-fourth-u-s-patent-for-key-cancer-immunotherapy-combination?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651147120","title":"Recce Wins Key Vietnamese Patent for Novel Anti-Infectives","url":"https://stock-news.laohu8.com/highlight/detail?id=2651147120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651147120?lang=en_us&edition=fundamental","pubTime":"2026-07-14 07:22","pubTimestamp":1783984922,"startTime":"0","endTime":"0","summary":"Recce Pharmaceuticals Ltd. ( ($AU:RCE) ) has provided an update. Recce Pharmaceuticals has secured a Vietnamese patent for its Family 4 anti-infect...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recce-wins-key-vietnamese-patent-for-novel-anti-infectives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recce-wins-key-vietnamese-patent-for-novel-anti-infectives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103822183","title":"Jiangxi Launches Pilot for Integrated \"One-Stop Intellectual Property Protection\" System","url":"https://stock-news.laohu8.com/highlight/detail?id=1103822183","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103822183?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:21","pubTimestamp":1783927270,"startTime":"0","endTime":"0","summary":"Recently, Jiangxi Province has initiated a pilot operation of its integrated service system for \"One-Stop Intellectual Property Protection\" on the Jiangxi Government Service Network and the \"Gan Fu...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRD","LRND","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651919675","title":"StemRIM Secures Canadian Patent for Regenerative Heart Drug Redasemtide","url":"https://stock-news.laohu8.com/highlight/detail?id=2651919675","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651919675?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:01","pubTimestamp":1783926076,"startTime":"0","endTime":"0","summary":"The latest update is out from StemRIM Inc. ( ($JP:4599) ). StemRIM Inc. said a medical use patent for its Regeneration-Inducing Medicine candidate ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/stemrim-secures-canadian-patent-for-regenerative-heart-drug-redasemtide?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/stemrim-secures-canadian-patent-for-regenerative-heart-drug-redasemtide?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USRD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":6,"totalSize":137,"code":"91000000","status":"200"}]}}